Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

STU:4E2 (USA)  
€ 2.70 (-1.46%) Sep 16
At Loss
P/B:
1.49
Market Cap:
€ 82.46M ($ 91.66M)
Enterprise V:
€ 18.93M ($ 21.04M)
Volume:
-
Avg Vol (2M):
-
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

AAPL Stock Intrinsic Values - Apple Inc